NO20070820L - Oktahydropyrrolo (2,3,C)pyridin-derivanter og farmasoytisk anvendelse derav. - Google Patents

Oktahydropyrrolo (2,3,C)pyridin-derivanter og farmasoytisk anvendelse derav.

Info

Publication number: NO20070820L
Authority: NO; Norway
Prior art keywords: octahydropyrrolo; diseases; pyridine derivatives; pharmaceutical use; fibrosis
Prior art date: 2004-07-21

Application number

NO20070820A

Other languages

English (en)

Norwegian (no)

Inventor

Dominique Swinnen

Agnes Bombrun

Original Assignee

Applied Research Systems

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-21

Filing date

2007-02-13

Publication date

2007-02-13

2007-02-13 Application filed by Applied Research Systems filed Critical Applied Research Systems

2007-02-13 Publication of NO20070820L publication Critical patent/NO20070820L/no

Links

150000003222 pyridines Chemical class 0.000 title abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
206010014561 Emphysema Diseases 0.000 abstract 1
206010016654 Fibrosis Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
206010003246 arthritis Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
208000019425 cirrhosis of liver Diseases 0.000 abstract 1
230000004761 fibrosis Effects 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
210000004185 liver Anatomy 0.000 abstract 1
201000006417 multiple sclerosis Diseases 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
208000005069 pulmonary fibrosis Diseases 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)

NO20070820A 2004-07-21 2007-02-13 Oktahydropyrrolo (2,3,C)pyridin-derivanter og farmasoytisk anvendelse derav. NO20070820L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US58962104P	2004-07-21	2004-07-21
EP04103483		2004-07-21
PCT/EP2005/053501 WO2006008303A1 (en)	2004-07-21	2005-07-20	Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof

Publications (1)

Publication Number	Publication Date
NO20070820L true NO20070820L (no)	2007-02-13

Family

ID=34929357

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20070820A NO20070820L (no)	2004-07-21	2007-02-13	Oktahydropyrrolo (2,3,C)pyridin-derivanter og farmasoytisk anvendelse derav.

Country Status (11)

Country	Link
US (1)	US7932389B2 (de)
EP (1)	EP1768979B1 (de)
JP (1)	JP5069108B2 (de)
AT (1)	ATE482956T1 (de)
AU (1)	AU2005263762C1 (de)
CA (1)	CA2572047C (de)
DE (1)	DE602005023874D1 (de)
ES (1)	ES2349940T3 (de)
IL (1)	IL180681A0 (de)
NO (1)	NO20070820L (de)
WO (1)	WO2006008303A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2011000512A (es) *	2008-07-14	2011-02-24	Novartis Ag	Inhibidores selectivos de mmp-12 y mmp-13 basados en acido hidroxamico.
LV15384B (lv)	2017-07-24	2019-05-20	Latvijas Organiskās Sintēzes Institūts	1-Acetil-5-nitro-4-fenil-3-pirolin-2-ons pielietošanai vēža ārstēšanā
JP7478142B2 (ja)	2018-06-07	2024-05-02	ディスアームセラピューティクス，インコーポレイテッド	Ｓａｒｍ１阻害剤
CA3123215C (en)	2018-12-19	2024-04-02	Disarm Therapeutics, Inc.	Inhibitors of sarm1 in combination with neuroprotective agents
KR20230038697A (ko) *	2020-07-14	2023-03-21	우한 엘엘 사이언스 앤드 테크놀로지 디벨롭먼트 컴퍼니, 리미티드	Rock 억제제 및 이의 제조 방법과 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2748026B1 (fr) *	1996-04-26	1998-06-05	Adir	Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU6228499A (en) *	1998-10-22	2000-05-08	Akzo Nobel N.V.	Tetrahydropyridopyridine derivatives and intermediates for producing the same
AR022423A1 (es) *	1999-01-27	2002-09-04	American Cyanamid Co	Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
WO2001083461A1 (en)	2000-04-28	2001-11-08	Shionogi & Co., Ltd.	Thiazole and oxazole derivatives
FR2821842B1 (fr) *	2001-03-07	2003-05-09	Servier Lab	Nouveaux derives d'inhibiteurs de mettalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6770647B2 (en)	2001-08-17	2004-08-03	Bristol-Myers Squibb Pharma Company	Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
JP4160357B2 (ja) *	2001-11-13	2008-10-01	株式会社資生堂	アザビシクロ化合物及びマトリックスメタロプロテアーゼ阻害物、皮膚外用剤

2005
- 2005-07-20 JP JP2007521948A patent/JP5069108B2/ja not_active Expired - Fee Related
- 2005-07-20 ES ES05777726T patent/ES2349940T3/es not_active Expired - Lifetime
- 2005-07-20 AT AT05777726T patent/ATE482956T1/de not_active IP Right Cessation
- 2005-07-20 EP EP05777726A patent/EP1768979B1/de not_active Expired - Lifetime
- 2005-07-20 DE DE602005023874T patent/DE602005023874D1/de not_active Expired - Lifetime
- 2005-07-20 CA CA2572047A patent/CA2572047C/en not_active Expired - Fee Related
- 2005-07-20 US US11/658,084 patent/US7932389B2/en not_active Expired - Fee Related
- 2005-07-20 WO PCT/EP2005/053501 patent/WO2006008303A1/en not_active Ceased
- 2005-07-20 AU AU2005263762A patent/AU2005263762C1/en not_active Ceased
2007
- 2007-01-11 IL IL180681A patent/IL180681A0/en unknown
- 2007-02-13 NO NO20070820A patent/NO20070820L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2349940T3 (es)	2011-01-13
AU2005263762A1 (en)	2006-01-26
AU2005263762C1 (en)	2012-03-01
CA2572047C (en)	2014-04-08
JP2008506752A (ja)	2008-03-06
IL180681A0 (en)	2007-06-03
EP1768979A1 (de)	2007-04-04
AU2005263762B2 (en)	2011-08-25
US20080146806A1 (en)	2008-06-19
EP1768979B1 (de)	2010-09-29
ATE482956T1 (de)	2010-10-15
DE602005023874D1 (de)	2010-11-11
WO2006008303A1 (en)	2006-01-26
JP5069108B2 (ja)	2012-11-07
CA2572047A1 (en)	2006-01-26
US7932389B2 (en)	2011-04-26

Legal Events

Date	Code	Title	Description
2008-01-14	CREP	Change of representative	Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS
2016-02-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20070994L (no)	2007-04-26	N-hydroksamid derivater og anvendelse derav
IL190835A0 (en)	2008-11-03	Sulfonamide derivatives, their preparation and use
EA201001127A1 (ru)	2011-02-28	Производные пиридина
IL167900A (en)	2013-06-27	Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease
NO20064120L (no)	2006-09-26	3-'4-heterocyklyl-1,2,3,-triazol-l-yll-N-aryl-benzamid er som inhibitorer av cytokinproduksjon for behandling av kroniske inflammatoriske sykdommer
GEP20084452B (en)	2008-08-10	Sulfonamide derivatives for the treatment of diseases
EA201001129A1 (ru)	2011-02-28	Пиримидины в качестве ингибиторов киназы
MY144634A (en)	2011-10-14	3-or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
UY29454A1 (es)	2006-11-30	Derivados novedosos de 7-amino-(1,3) tiazol(4,5-d) pirimidina 5-sustituidos
EA200601462A1 (ru)	2007-04-27	Соединения для лечения заболеваний
IL180681A0 (en)	2007-06-03	Pyridine derivatives, their preparation and use
NO20074458L (no)	2007-10-31	N-hydroksamidderivater og anvendelse derav
EA200701348A1 (ru)	2007-12-28	Сульфониламиноциклические соединения и их применение
CY1112088T1 (el)	2015-11-04	Παραγωγα ν-υδροξυαμιδης και η χρηση τους
NO20073633L (no)	2007-09-21	Sulfonylamino sykliske derivater og anvendelse derav
UA88785C2 (en)	2009-11-25	N-hydroxyamide derivatives and use thereof
NO20064806L (no)	2006-12-21	Formamidderivater anvendelige som adenoceptor
NO20064805L (no)	2006-12-01	Sammensetninger for behandling av sykdommer
WO2007059950A3 (en)	2007-08-02	Dry powder pharmaceutical formulations of purine a2a agonists